Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

19.0%

11 terminated/withdrawn out of 58 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

41%

24 trials in Phase 3/4

Results Transparency

70%

31 of 44 completed trials have results

Key Signals

1 recruiting31 with results9 terminated

Enrollment Performance

Analytics

Phase 4
17(36.2%)
N/A
13(27.7%)
Phase 3
7(14.9%)
Phase 2
7(14.9%)
Phase 1
3(6.4%)
47Total
Phase 4(17)
N/A(13)
Phase 3(7)
Phase 2(7)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (58)

Showing 20 of 58 trials
NCT04563520Phase 3Recruiting

SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis

Role: collaborator

NCT05368038Enrolling By Invitation

ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program

Role: collaborator

NCT00904046Not ApplicableCompleted

Pathophysiology of Uric Acid Nephrolithiasis

Role: collaborator

NCT04119336Phase 2Terminated

Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma

Role: collaborator

NCT00645801Phase 4Completed

Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation

Role: collaborator

NCT01161394Phase 4Completed

Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study

Role: collaborator

NCT02749721Phase 4Completed

The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder

Role: collaborator

NCT03063957Unknown

Identification/Characterization of Changes in Microscopic Colitis

Role: collaborator

NCT04675086Phase 3Withdrawn

Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection

Role: collaborator

NCT01048840Completed

Natural History of Gastroesophageal Reflux (GER) in Children < 12 Years of Age

Role: collaborator

NCT00822471Not ApplicableCompleted

Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library

Role: collaborator

NCT00677508Completed

Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling

Role: collaborator

NCT00091949Phase 3Completed

Insulin Resistance Intervention After Stroke Trial

Role: collaborator

NCT01023620Not ApplicableCompleted

HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)

Role: collaborator

NCT01112982Phase 4Completed

An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.

Role: collaborator

NCT00642694Phase 3Terminated

Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon

Role: collaborator

NCT00242177Phase 1Completed

Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability

Role: collaborator

NCT01190020Phase 1Completed

Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation.

Role: collaborator

NCT00770367Phase 4Completed

Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes

Role: collaborator

NCT00315146Phase 4Completed

Optimizing Body Composition for Function in Older Adults

Role: collaborator